ClinicalTrials.Veeva

Menu

Effectiveness of Perineorrhaphy in Pelvic Organ Prolapse Surgery (PINPOPS)

L

Lund University

Status

Completed

Conditions

Pelvic Organ Prolapse (POP)
Pelvic Organ Prolapse Vaginal Surgery

Treatments

Procedure: Perineorrhaphy
Procedure: No perineorrhaphy

Study type

Observational

Funder types

Other

Identifiers

NCT07006129
EPMDnr 2023-00177-01 (Study 1)

Details and patient eligibility

About

This is an observational registry-based study of long-term outcome after vaginal native tissue repair for pelvic organ prolapse designed to emulate a pragmatic open-label two-arm trial for which patients, in whom perineorrhaphy is not strictly indicated but clinically tenable, perioperatively are randomized to concomitant perineorrhaphy or not.

Full description

This is an emulated pragmatic open-label two-arm trial in patients undergoing native tissue repair surgery for pelvic organ prolapse, in which patients are randomized perioperatively to either concomitant perineorrhaphy or not. The target population is the large group of patients for whom, at the discretion of the surgeon, this intervention is currently an option while not being strictly indicated. The investigators assumed that women were randomly assigned perioperatively to either strategy within levels of baseline co-variables: age, BMI, parity, lung disease, ASA-classification, constipation, hypermobility, prolapse in which vaginal compartment and if surgery is performed on it, year of primary surgery and region. Data was obtained from The Swedish National Quality Register of Gynaecological Surgery (GynOp), the Swedish National Patient Register, the Swedish Medical Birth Register, and the Swedish Cause of Death Register. In order to emulate a target trial, multiple imputation of missing data is followed by controlling for confounding through inverse probability weighting (IPW) in order to estimate the average treatment effect (ATE) in the primary analysis. In the secondary analysis, the primary analysis will be repeated but with overlap weights. Additional analyses: The sample will be re-weighted using IPW to estimate the average treatment effect on the treated (ATT). Restricted mean survival time (RMST) will be calculated at five years of follow-up for the primary outcome. Bias analysis: Mortality during follow up for the primary outcome will be used as a negative control.

Enrollment

40,646 patients

Sex

Female

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Pelvic organ prolapse surgery with vaginal native tissue repair without concomitant hysterectomy.

Exclusion criteria

  • Primary surgery with colpocleisis, use of mesh, laparoscopic or abdominal surgery, concomitant incontinence surgery (eg transvaginal tape).
  • Previous hysterectomy
  • Previous pelvic organ prolapse surgery

Trial design

40,646 participants in 2 patient groups

Perineorrhaphy
Description:
Primary pelvic organ prolapse surgery (no concomitant hysterectomy) with native tissue repair including perineorrhaphy
Treatment:
Procedure: Perineorrhaphy
No perineorrhaphy
Description:
Primary pelvic organ prolapse surgery (no concomitant hysterectomy) with native tissue repair excluding perineorrhaphy
Treatment:
Procedure: No perineorrhaphy

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems